- Home
- PFSI vs BSX Comparison
PFSI vs BSX Comparison
Compare PFSI & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFSI | BSX |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 149.7B |
| IPO Year | 2013 | 1992 |
Fundamental Metrics
Financial Performance| Metric | PFSI | BSX |
|---|---|---|
| Price | $130.48 | $92.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 19 |
| Target Price | ★ $138.67 | $124.53 |
| AVG Volume (30 Days) | 330.5K | ★ 9.7M |
| Earning Date | 01-29-2026 | 10-22-2025 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ 191.00 | 54.68 |
| EPS | ★ 9.30 | 1.87 |
| Revenue | $2,723,457,000.00 | ★ $19,349,000,000.00 |
| Revenue This Year | $5.53 | $21.05 |
| Revenue Next Year | $29.51 | $11.43 |
| P/E Ratio | ★ $14.03 | $49.51 |
| Revenue Growth | 21.25 | ★ 21.61 |
| 52 Week Low | $85.74 | $85.98 |
| 52 Week High | $136.62 | $109.50 |
Technical Indicators
Market Signals| Indicator | PFSI | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 52.66 | 33.35 |
| Support Level | $127.84 | $91.45 |
| Resistance Level | $133.51 | $93.89 |
| Average True Range (ATR) | 3.20 | 2.10 |
| MACD | -0.35 | -0.83 |
| Stochastic Oscillator | 39.79 | 10.42 |
Price Performance
Historical ComparisonAbout PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.